Summary
76 / 100 · Bulios Score
What speaks for it
- It earns 19 USD a year on every 100 USD of invested capital.
- Earnings per share grew by 14% a year over the last 3 years.
- It bought back its own shares for $10.1B in the last fiscal year, 10% of its market value.
- You pay 14.4 USD for 1 USD of yearly profit, little for its sector.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 14.4 USD for 1 USD of yearly profit. Over the last five years it was 13.7 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.0% a year over 5 years. Over the last 3 years it grew by 7.9% a year. For the next fiscal year analysts expect revenue to grow by 3.8%. Earnings per share grew by 14% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 72 USD
- Sales and administration 13 USD
- Taxes and other 6.7 USD
- Net profit 8.8 USD
Net profit, industry median (Medical - Care Facilities) 6.7 USD
Out of every 100 USD of revenue, 8.8 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 8.1 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.67%
- Paid out of profit
- 9.7%
- Raised in a row
- 5 years
You receive $3.06 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 29
- Hold 15
- Sell 2
Today's price within the analysts' price targets
The average target of $457.53 is 0.6% above today's price. 63% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Managed Care And Other Insurers 51%
- Managed Medicare 18%
- Medicare 15%
- Medicaid 8.1%
- Managed Medicaid 5.0%
- Other 2.5%
By region
- American Group 37%
- Atlantic Group 34%
- National Group 29%
Managed Care And Other Insurers brings in 51% of revenue. Medicaid grew fastest, by 27% a year.
Segments in detail